Protocol Ledger

NCT07060885 · Phase III · COMPLETED

A Research Study of House Dust Mite (HDM) SLIT-tablet for the Treatment of HDM Allergy in Chinese Participants Aged 12-65

Interventional Phase III clinical trial protocol NCT07060885 sponsored by ALK-Abelló in Respiratory and Pulmonary, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2025-09-01 Enrollment: 327 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT07060885
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)327 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)3 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT07060885
Protocol FieldVerified Registry Value
NCT IdentifierNCT07060885
Consolidated Lead SponsorALK-Abelló
Therapeutic Condition CohortRespiratory and Pulmonary
Clinical Trial PhasePhase III
Overall Recruitment StatusCOMPLETED
Registered Enrollment327 participants (ACTUAL)
Registered Start Date2025-09-01
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Respiratory and Pulmonary Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI